From: The role of miRNA20a and miRNA320 in Iraqi patients with COVID-19: a case–control study
miRNAs | Control (n = 145) ΔCT (mean ± SD) | Patient (n = 145) ΔCT (mean ± SD) | p-value |
---|---|---|---|
miRNA-20a | 7.66 ± 1.11 | 4.02 ± 0.34 | < 0.0001**** |
miRNA-320 | 4.90 ± 0.60 | 6.00 ± 0.39 | < 0.0001**** |